Biochemical pharmacology of the sigma-1 receptor

Molecular Pharmacology

Volumn 89, Issue 1, 2016, Pages 142-153

  Chu, Uyen B ^a   Ruoho, Arnold E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 PHENYLCYCLOHEXANECARBOXYLIC ACID 2 MORPHOLINOETHYL ESTER; 1 [2 (3,4 DICHLOROPHENYL)ETHYL] 4 METHYLPIPERAZINE; 2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; AMINO ACID; CHAPERONE; CHLORPHENIRAMINE; DIMER; FENPROPIMORPH; FLUVOXAMINE; GLUCOSE REGULATED PROTEIN 78; HALOPERIDOL; LIPID; MEMBRANE PROTEIN; METHAMPHETAMINE; MONOMER; N ALLYLNORMETAZOCINE; N [2 (3,4 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; N,N DIMETHYLTRYPTAMINE; OPIATE AGONIST; OPIATE ANTAGONIST; PENTAZOCINE; PROGESTERONE; RIMCAZOLE; SIGMA 1 OPIATE RECEPTOR; SIGMA 1 OPIATE RECEPTOR AGONIST; SIGMA 1 OPIATE RECEPTOR ANTAGONIST; SMALL HEAT SHOCK PROTEIN; TETRAMER; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL; NARCOTIC ANALGESIC AGENT; PROTEIN BINDING; SIGMA OPIATE RECEPTOR; SIGMA-1 RECEPTOR;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL STRESS; DRUG MECHANISM; DRUG TARGETING; HUMAN; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MOLECULAR PHARMACOLOGY; MOLECULAR PROBE; MOLECULE; NONHUMAN; OLIGOMERIZATION; PHARMACOLOGY; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SITE DIRECTED MUTAGENESIS; AGONISTS; ANIMAL; CELL MEMBRANE; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANALGESICS, OPIOID; ANIMALS; CELL MEMBRANE; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RECEPTORS, SIGMA;

EID: 84958254355     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.115.101170     Document Type: Review

References (118)

1. Al-Saif A, Al-Mohanna F, and Bohlega S (2011) A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann Neurol 70:913-919
2. Albuquerque EX, Pereira EF, Alkondon M, and Rogers SW (2009) Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 89:73-120
3. Aydar E, Palmer CP, Klyachko VA, and Jackson MB (2002) The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 34:399-410
4. Balasuriya D, DSa L, Talker R, Dupuis E, Maurin F, Martin P, Borgese F, Soriani O, and Edwardson JM (2014) A direct interaction between the sigma-1 receptor and the hERG voltage-gated K1 channel revealed by atomic force microscopy and homogeneous time-resolved fluorescence (HTRF®). J Biol Chem 289:32353-32363
5. Balasuriya D, Stewart AP, Crotts D, Borgese F, Soriani O, and Edwardson JM (2012) The sigma-1 receptor binds to the Nav1.5 voltage-gated Na1 channel with 4- fold symmetry. J Biol Chem 287:37021-37029
6. Balasuriya D, Stewart AP, and Edwardson JM (2013) The s-1 receptor interacts directly with GluN1 but not GluN2A in the GluN1/GluN2A NMDA receptor. J Neurosci 33:18219-18224
7. Basha E, ONeill H, and Vierling E (2012) Small heat shock proteins and a-crystallins: dynamic proteins with flexible functions. Trends Biochem Sci 37:106-117
8. Bowen WD, Hellewell SB, and McGarry KA (1989) Evidence for a multi-site model of the rat brain sigma receptor. Eur J Pharmacol 163:309-318
9. Brune S, Pricl S, and Wnsch B (2013) Structure of the s1 receptor and its ligand binding site. J Med Chem 56:9809-9819
10. Brune S, Schepmann D, Klempnauer KH, Marson D, Dal Col V, Laurini E, Fermeglia M, Wnsch B, and Pricl S (2014) The sigma enigma: in vitro/in silico site-directed mutagenesis studies unveil s1 receptor ligand binding. Biochemistry 53:2993-3003
11. Bucolo C, Drago F, Lin LR, and Reddy VN (2006) Sigma receptor ligands protect human retinal cells against oxidative stress. Neuroreport 17:287-291
12. Carnally SM, Johannessen M, Henderson RM, Jackson MB, and Edwardson JM (2010) Demonstration of a direct interaction between sigma-1 receptors and acidsensing ion channels. Biophys J 98:1182-1191
13. Carver JA, Rekas A, Thorn DC, and Wilson MR (2003) Small heat-shock proteins and clusterin: intra- and extracellular molecular chaperones with a common mechanism of action and function? IUBMB Life 55:661-668
14. Chen Y, Hajipour AR, Sievert MK, Arbabian M, and Ruoho AE (2007) Characterization of the cocaine binding site on the sigma-1 receptor. Biochemistry 46: 3532-3542
15. Chu UB, Hajipour AR, Ramachandran S, and Ruoho AE (2011) Characterization of interactions of 4-nitrophenylpropyl-N-alkylamine with receptors. Biochemistry 50:7568-7578
16. Chu UB, Ramachandran S, Hajipour AR, and Ruoho AE (2013) Photoaffinity labeling of the sigma-1 receptor with N-[3-(4-nitrophenyl)propyl]-N-dodecylamine: evidence of receptor dimers. Biochemistry 52:859-868
17. de Costa BR, Bowen WD, Hellewell SB, Walker JM, Thurkauf A, Jacobson AE, and Rice KC (1989) Synthesis and evaluation of optically pure [3H]-(1)-pentazocine, a highly potent and selective radioligand for sigma receptors. FEBS Lett 251: 53-58
18. Fehr , Juhsz A, Lszl A, Klmn J, Jr, Pkski M, Klmn J, and Janka Z (2012) Association between a variant of the sigma-1 receptor gene and Alzheimers disease. Neurosci Lett 517:136-139
19. Fontanilla D, Hajipour AR, Pal A, Chu UB, Arbabian M, and Ruoho AE (2008) Probing the steroid binding domain-like I (SBDLI) of the sigma-1 receptor binding site using N-substituted photoaffinity labels. Biochemistry 47:7205-7217
20. Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, and Ruoho AE (2009) The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 323:934-937
21. Fukunaga K, Shinoda Y, and Tagashira H (2015) The role of SIGMAR1 gene mutation and mitochondrial dysfunction in amyotrophic lateral sclerosis. J Pharmacol Sci 127:36-41
22. Ganapathy ME, Prasad PD, Huang W, Seth P, Leibach FH, and Ganapathy V (1999) Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line. J Pharmacol Exp Ther 289:251-260
23. Garner E, Romero P, Dunker AK, Brown C, and Obradovic Z (1999) Predicting binding regions within disordered proteins. Genome Inform Ser Workshop Genome Inform 10:41-50
24. Gether U and Kobilka BK (1998) G protein-coupled receptors. II. Mechanism of agonist activation. J Biol Chem 273:17979-17982
25. Glennon RA (2005) Pharmacophore identification for sigma-1 (sigma1) receptor binding: application of the deconstruction-reconstruction-elaboration approach. Mini Rev Med Chem 5:927-940
26. Gromek KA, Meddaugh HR, Wrobel RL, Suchy FP, Bingman CA, Primm JG, and Fox BG (2013) Improved expression and purification of sigma 1 receptor fused to maltose binding protein by alteration of linker sequence. Protein Expr Purif 89: 203-209
27. Gromek KA, Suchy FP, Meddaugh HR, Wrobel RL, LaPointe LM, Chu UB, Primm JG, Ruoho AE, Senes A, and Fox BG (2014) The oligomeric states of the purified sigma-1 receptor are stabilized by ligands. J Biol Chem 289:20333-20344
28. Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, and Glossmann H (1996) Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci USA 93:8072-8077
29. Hannun YA and Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139-150
30. Hatters DM, Wilson MR, Easterbrook-Smith SB, and Howlett GJ (2002) Suppression of apolipoprotein C-II amyloid formation by the extracellular chaperone, clusterin. Eur J Biochem 269:2789-2794
31. Hayashi T, Hayashi E, Fujimoto M, Sprong H, and Su TP (2012) The lifetime of UDPgalactose: ceramide galactosyltransferase is controlled by a distinct endoplasmic reticulum-associated degradation (ERAD) regulated by sigma-1 receptor chaperones. J Biol Chem 287:43156-43169
32. Hayashi T and Su TP (2001) Regulating ankyrin dynamics: roles of sigma-1 receptors. Proc Natl Acad Sci USA 98:491-496
33. Hayashi T and Su TP (2003) Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. J Pharmacol Exp Ther 306:718-725
34. Hayashi T and Su TP (2004) Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation. Proc Natl Acad Sci USA 101:14949-14954
35. Hayashi T and Su TP (2007) Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(21) signaling and cell survival. Cell 131:596-610
36. Hellewell SB and Bowen WD (1990) A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (1)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res 527:244-253
37. Hofmann K and Stoffel E (1993) TMBase: a dataset of membrane spanning proteins segments (Abstract). Biol Chem Hoppe-Seyler 374:166 DOI: 10.1515/ bchm3.1993.374.1-6.143.
38. Horvth I, Multhoff G, Sonnleitner A, and Vgh L (2008) Membrane-associated stress proteins: more than simply chaperones. Biochim Biophys Acta 1778:1653-1664
39. Itzhak Y (1987) [3H]PCP-3-OH and (1)[3H]SKF 10047 binding sites in rat brain membranes: evidence of multiplicity. Eur J Pharmacol 136:231-234
40. Kahoun JR and Ruoho AE (1992) (125I)iodoazidococaine, a photoaffinity label for the haloperidol-sensitive sigma receptor. Proc Natl Acad Sci USA 89:1393-1397
41. Kavanaugh MP, Parker J, Bobker DH, Keana JF, and Weber E (1989) Solubilization and characterization of sigma-receptors from guinea pig brain membranes. J Neurochem 53:1575-1580
42. Kim FJ, Kovalyshyn I, Burgman M, Neilan C, Chien CC, and Pasternak GW (2010) Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding. Mol Pharmacol 77: 695-703
43. Kinoshita M, Matsuoka Y, Suzuki T, Mirrielees J, and Yang J (2012) Sigma-1 receptor alters the kinetics of Kv1.3 voltage gated potassium channels but not the sensitivity to receptor ligands. Brain Res 1452:1-9
44. Kourrich S, Hayashi T, Chuang JY, Tsai SY, Su TP, and Bonci A (2013) Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine. Cell 152:236-247
45. Kumagai K, Shono K, Nakayama H, Ohno Y, and Saji I (2000) (2R-trans)-2-butyl-5- heptylpyrrolidine as a potent sigma receptor ligand produced by Streptomyces longispororuber. J Antibiot (Tokyo) 53:467-473
46. Largent BL, Gundlach AL, and Snyder SH (1984) Psychotomimetic opiate receptors labeled and visualized with (1)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. Proc Natl Acad Sci USA 81:4983-4987
47. Largent BL, Gundlach AL, and Snyder SH (1986) Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (1)-[3H]SKF 10,047, (1)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. J Pharmacol Exp Ther 238: 739-748
48. Largent BL, Wikstrm H, Gundlach AL, and Snyder SH (1987) Structural determinants of sigma receptor affinity. Mol Pharmacol 32:772-784
49. Li X, Romero P, Rani M, Dunker AK, and Obradovic Z (1999) Predicting protein disorder for N-, C-, and internal regions. Genome Inform Ser Workshop Genome Inform 10:30-40
50. Luty AA, Kwok JB, Dobson-Stone C, Loy CT, Coupland KG, Karlstrm H, Sobow T, Tchorzewska J, Maruszak A, and Barcikowska M et al. (2010) Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann Neurol 68:639-649
51. Maeda DY, Williams W, Kim WE, Thatcher LN, Bowen WD, and Coop A (2002) Narylalkylpiperidines as high-affinity sigma-1 and sigma-2 receptor ligands: phenylpropylamines as potential leads for selective sigma-2 agents. Bioorg Med Chem Lett 12:497-500
52. Mancuso R, Olivn S, Rando A, Casas C, Osta R, and Navarro X (2012) Sigma-1R agonist improves motor function and motoneuron survival in ALS mice. Neurotherapeutics 9:814-826
53. Manglik A and Kobilka B (2014) The role of protein dynamics in GPCR function: insights from the b2AR and rhodopsin. Curr Opin Cell Biol 27:136-143
54. Martin WR (1983) Pharmacology of opioids. Pharmacol Rev 35:283-323
55. Martin WR, Eades CG, Thompson JA, Huppler RE, and Gilbert PE (1976) The effects of morphine- and nalorphine- like drugs in the nondependent and morphinedependent chronic spinal dog. J Pharmacol Exp Ther 197:517-532
56. Mavlyutov TA, Epstein ML, Andersen KA, Ziskind-Conhaim L, and Ruoho AE (2010) The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study. Neuroscience 167:247-255
57. Mavlyutov TA, Epstein ML, Liu P, Verbny YI, Ziskind-Conhaim L, and Ruoho AE (2012) Development of the sigma-1 receptor in C-terminals of motoneurons and colocalization with the N,N9-dimethyltryptamine forming enzyme, indole-N-methyl transferase. Neuroscience 206:60-68
58. Mavlyutov TA, Epstein ML, Verbny YI, Huerta MS, Zaitoun I, Ziskind-Conhaim L, and Ruoho AE (2013) Lack of sigma-1 receptor exacerbates ALS progression in mice. Neuroscience 240:129-134
59. Mavlyutov TA, Guo LW, Epstein ML, and Ruoho AE (2015) Role of the sigma-1 receptor in amyotrophic lateral sclerosis (ALS). J Pharmacol Sci 127:10-16
60. Mavlyutov TA, Nickells RW, and Guo LW (2011) Accelerated retinal ganglion cell death in mice deficient in the sigma-1 receptor. Mol Vis 17:1034-1043
61. Mavlyutov TA and Ruoho AE (2007a) Ligand-dependent localization and intracellular stability of sigma-1 receptors in CHO-K1 cells. J Mol Signal 2:8.
62. McHaourab HS, Godar JA, and Stewart PL (2009) Structure and mechanism of protein stability sensors: chaperone activity of small heat shock proteins. Biochemistry 48:3828-3837
63. McLean S and Weber E (1988) Autoradiographic visualization of haloperidolsensitive sigma receptors in guinea-pig brain. Neuroscience 25:259-269
64. Milligan G (2003) Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. Mol Pharmacol 64:1271-1276
65. Mishina M, Ishiwata K, Ishii K, Kitamura S, Kimura Y, Kawamura K, Oda K, Sasaki T, Sakayori O, and Hamamoto M et al. (2005) Function of sigma1 receptors in Parkinsons disease. Acta Neurol Scand 112:103-107
66. Mishra AK, Mavlyutov T, Singh DR, Biener G, Yang J, Oliver JA, Ruoho A, and Raicu V (2015) The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands. Biochem J 466:263-271
67. Moebius FF, Bermoser K, Reiter RJ, Hanner M, and Glossmann H (1996) Yeast sterol C8-C7 isomerase: identification and characterization of a high-affinity binding site for enzyme inhibitors. Biochemistry 35:16871-16878
68. Moebius FF, Burrows GG, Hanner M, Schmid E, Striessnig J, and Glossmann H (1993) Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies. Mol Pharmacol 44:966-971
69. Moebius FF, Reiter RJ, Hanner M, and Glossmann H (1997) High affinity of sigma 1- binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol C8-C7 isomerase. Br J Pharmacol 121:1-6
70. Monnet FP, Debonnel G, Junien JL, and De Montigny C (1990) N-methyl-Daspartate- induced neuronal activation is selectively modulated by sigma receptors. Eur J Pharmacol 179:441-445
71. Mori T, Hayashi T, Hayashi E, and Su TP (2013) Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival. PLoS One 8:e76941.
72. Mori T, Hayashi T, and Su TP (2012) Compromising s-1 receptors at the endoplasmic reticulum render cytotoxicity to physiologically relevant concentrations of dopamine in a nuclear factor-kB/Bcl-2-dependent mechanism: potential relevance to Parkinsons disease. J Pharmacol Exp Ther 341:663-671
73. Natsvlishvili N, Goguadze N, Zhuravliova E, and Mikeladze D (2015) Sigma-1 receptor directly interacts with Rac1-GTPase in the brain mitochondria. BMC Biochem 16:11.
74. Navarro G, Moreno E, Aymerich M, Marcellino D, McCormick PJ, Mallol J, Corts A, Casad V, Canela EI, and Ortiz J et al. (2010) Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine. Proc Natl Acad Sci USA 107:18676-18681
75. Nguyen L, Lucke-Wold BP, Mookerjee SA, Cavendish JZ, Robson MJ, Scandinaro AL, and Matsumoto RR (2015) Role of sigma-1 receptors in neurodegenerative diseases. J Pharmacol Sci 127:17-29
76. Ortega-Roldan JL, Ossa F, Amin NT, and Schnell JR (2015) Solution NMR studies reveal the location of the second transmembrane domain of the human sigma-1 receptor. FEBS Lett 589:659-665
77. Ortega-Roldan JL, Ossa F, and Schnell JR (2013) Characterization of the human sigma-1 receptor chaperone domain structure and binding immunoglobulin protein (BiP) interactions. J Biol Chem 288:21448-21457
78. Overton MC, Chinault SL, and Blumer KJ (2003) Oligomerization, biogenesis, and signaling is promoted by a glycophorin A-like dimerization motif in transmembrane domain 1 of a yeast G protein-coupled receptor. J Biol Chem 278: 49369-49377
79. Pabba M, Wong AY, Ahlskog N, Hristova E, Biscaro D, Nassrallah W, Ngsee JK, Snyder M, Beique JC, and Bergeron R (2014) NMDA receptors are upregulated and trafficked to the plasma membrane after sigma-1 receptor activation in the rat hippocampus. J Neurosci 34:11325-11338
80. Pal A, Chu UB, Ramachandran S, Grawoig D, Guo LW, Hajipour AR, and Ruoho AE (2008) Juxtaposition of the steroid binding domain-like I and II regions constitutes a ligand binding site in the sigma-1 receptor. J Biol Chem 283:19646-19656
81. Pal A, Fontanilla D, Gopalakrishnan A, Chae YK, Markley JL, and Ruoho AE (2012) The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements. Eur J Pharmacol 682:12-20
82. Pal A, Hajipour AR, Fontanilla D, Ramachandran S, Chu UB, Mavlyutov T, and Ruoho AE (2007) Identification of regions of the sigma-1 receptor ligand binding site using a novel photoprobe. Mol Pharmacol 72:921-933
83. Palmer CP, Mahen R, Schnell E, Djamgoz MB, and Aydar E (2007) Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines. Cancer Res 67: 11166-11175
84. Poon S, Easterbrook-Smith SB, Rybchyn MS, Carver JA, and Wilson MR (2000) Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state. Biochemistry 39: 15953-15960
85. Poulain P, Gelly JC, and Flatters D (2010) Detection and architecture of small heat shock protein monomers. PLoS One 5:e9990.
86. Prause J, Goswami A, Katona I, Roos A, Schnizler M, Bushuven E, Dreier A, Buchkremer S, Johann S, and Beyer C et al. (2013) Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis. Hum Mol Genet 22:1581-1600
87. Ramachandran S (2008) Biochemical Studies on the Sigma-1 Receptor: A Multidrug Binding Protein of Enigmatic Function. Doctoral dissertation, University of Wisconsin- Madison
88. Ramachandran S, Chu UB, Mavlyutov TA, Pal A, Pyne S, and Ruoho AE (2009) The sigma1 receptor interacts with N-alkyl amines and endogenous sphingolipids. Eur J Pharmacol 609:19-26
89. Ramachandran S, Lu H, Prabhu U, and Ruoho AE (2007) Purification and characterization of the guinea pig sigma-1 receptor functionally expressed in Escherichia coli. Protein Expr Purif 51:283-292
90. Renaudo A, LHoste S, Guizouarn H, Borgse F, and Soriani O (2007) Cancer cell cycle modulated by a functional coupling between sigma-1 receptors and Cl2 channels. J Biol Chem 282:2259-2267
91. Ruoho AE, Chu UB, Ramachandran S, Fontanilla D, Mavlyutov T, and Hajipour AR (2012) The ligand binding region of the sigma-1 receptor: studies utilizing photoaffinity probes, sphingosine and N-alkylamines. Curr Pharm Des 18:920-929
92. Seth P, Ganapathy ME, Conway SJ, Bridges CD, Smith SB, Casellas P, and Ganapathy V (2001) Expression pattern of the type 1 sigma receptor in the brain and identity of critical anionic amino acid residues in the ligand-binding domain of the receptor. Biochim Biophys Acta 1540:59-67
93. Sharkey J, Glen KA, Wolfe S, and Kuhar MJ (1988) Cocaine binding at sigma receptors. Eur J Pharmacol 149:171-174
94. Shimazawa M, Sugitani S, Inoue Y, Tsuruma K, and Hara H (2015) Effect of a sigma- 1 receptor agonist, cutamesine dihydrochloride (SA4503), on photoreceptor cell death against light-induced damage. Exp Eye Res 132:64-72
95. Sigel E and Steinmann ME (2012) Structure, function, and modulation of GABA(A) receptors. J Biol Chem 287:40224-40231
96. Sircar R, Nichtenhauser R, Ieni JR, and Zukin SR (1986a) Characterization and autoradiographic visualization of (1)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/sigma opiate receptor commonality. J Pharmacol Exp Ther 237:681-688
97. Sircar R, Samaan H, Nichtenhauser R, Snell LD, Johnson KM, Rivier J, Vale W, Zukin RS, and Zukin SR (1986b) Modulation of brain NMDA receptors: common mechanism of sigma/PCP receptors and their exogenous and endogenous ligands. NIDA Res Monogr 75:157-160
98. Smith SB, Duplantier J, Dun Y, Mysona B, Roon P, Martin PM, and Ganapathy V (2008) In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (1)-pentazocine. Invest Ophthalmol Vis Sci 49:4154-4161
99. Spiegel S and Milstien S (2007) Functions of the multifaceted family of sphingosine kinases and some close relatives. J Biol Chem 282:2125-2129
100. Su T-P (1981) Psychotomimetic opioid binding: specific binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. Eur J Pharmacol 75:81-82
101. Su TP and Hayashi T (2003) Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr Med Chem 10:2073-2080
102. Su TP, Hayashi T, Maurice T, Buch S, and Ruoho AE (2010) The sigma-1 receptor chaperone as an inter-organelle signaling modulator. Trends Pharmacol Sci 31: 557-566
103. Su TP, London ED, and Jaffe JH (1988) Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science 240:219-221
104. Tam SW (1983) Naloxone-inaccessible sigma receptor in rat central nervous system. Proc Natl Acad Sci USA 80:6703-6707
105. Tam SW and Cook L (1984) Sigma opiates and certain antipsychotic drugs mutually inhibit (1)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes. Proc Natl Acad Sci USA 81:5618-5621
106. Tchedre KT, Huang RQ, Dibas A, Krishnamoorthy RR, Dillon GH, and Yorio T (2008) Sigma-1 receptor regulation of voltage-gated calcium channels involves a direct interaction. Invest Ophthalmol Vis Sci 49:4993-5002
107. Tsai SY, Hayashi T, Harvey BK, Wang Y, Wu WW, Shen RF, Zhang Y, Becker KG, Hoffer BJ, and Su TP (2009) Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1xGTP pathway. Proc Natl Acad Sci USA 106:22468-22473
108. Tsai SY, Pokrass MJ, Klauer NR, De Credico NE, and Su TP (2014) Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders. Expert Opin Ther Targets 18:1461-1476
109. Tsai SY, Pokrass MJ, Klauer NR, Nohara H, and Su TP (2015) Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid. Proc Natl Acad Sci USA 112:6742-6747
110. Tuerxun T, Numakawa T, Adachi N, Kumamaru E, Kitazawa H, Kudo M, and Kunugi H (2010) SA4503, a sigma-1 receptor agonist, prevents cultured cortical neurons from oxidative stress-induced cell death via suppression of MAPK pathway activation and glutamate receptor expression. Neurosci Lett 469:303-308
111. Van Montfort R, Slingsby C, and Vierling E (2001) Structure and function of the small heat shock protein/alpha-crystallin family of molecular chaperones. Adv Protein Chem 59:105-156
112. Vaupel DB (1983) Naltrexone fails to antagonize the sigma effects of PCP and SKF 10,047 in the dog. Eur J Pharmacol 92:269-274
113. Weber E, Sonders M, Quarum M, McLean S, Pou S, and Keana JF (1986) 1,3-Di(2-[5- 3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc Natl Acad Sci USA 83: 8784-8788
114. Wilson MR and Easterbrook-Smith SB (2000) Clusterin is a secreted mammalian chaperone. Trends Biochem Sci 25:95-98
115. Wu Z and Bowen WD (2008) Role of sigma-1 receptor C-terminal segment in inositol 1,4,5-trisphosphate receptor activation: constitutive enhancement of calcium signaling in MCF-7 tumor cells. J Biol Chem 283:28198-28215
116. Yamamoto H, Miura R, Yamamoto T, Shinohara K, Watanabe M, Okuyama S, Nakazato A, and Nukada T (1999) Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding. FEBS Lett 445: 19-22
117. Yin J, Sha S, Chen T, Wang C, Hong J, Jie P, Zhou R, Li L, Sokabe M, and Chen L (2015) Sigma-1 (s) receptor deficiency reduces b-amyloid(25-35)-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B. Neuropharmacology 89:215-224
118. Zhang H and Cuevas J (2002) Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons. J Neurophysiol 87: 2867-2879